US Stocks
/
Fate Therapeutics, Inc. Share Price
Fate Therapeutics, Inc. Share Price

Fate Therapeutics, Inc. Share Price

NASDAQ: FATE | Micro Cap
$2.17
+$0.04 (2.12%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Fate Therapeutics, Inc. Stock Performance

Open
$2.13
Prev. Close
$2.13
Circuit Range
N/A
Day Range
$2.13 - $2.27
Year Range
$0.95 - $3.23
Volume
53,380
Average Traded
$2.20

Fate Therapeutics, Inc. Share Price Today

As of 12 October 2026, Fate Therapeutics, Inc.'s share price is $2.17. The stock opened at $2.13, compared to its previous close of $2.13. During today's trading session, Fate Therapeutics, Inc.'s share price traded between $2.13 and $2.27, with an average price of $2.20. Over the past 52 weeks, the stock has recorded a high of $3.23 and a low of $0.95. In terms of performance, Fate Therapeutics, Inc.'s share price has risen by 73.60% over the last six months and is up 58.97% on a year-on-year basis.

Fate Therapeutics, Inc. Share Price Chart

$2.13$2.27
L
Show Current Price
H

Fate Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$257.77M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.05
Revenue (TTM)
$6.65B
Return On Equity (TTM)
-82.12%
Profit Margin
-2049.92%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
6.48%

Fate Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$1.74$1.37$1.30$2.08
Net Profit-$32.25-$32.37-$31.21-$30.16
Net Profit Margin-1853.45%-2362.77%-2400.77%-1450.00%
Income ChangeN/A-0.37%3.58%3.36%

Fate Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$96.30$63.53$13.63$6.65
Net Profit-$281.72-$160.93-$186.26-$136.32
Net Profit Margin-292.54%-253.31%-1366.54%-2049.92%
Income ChangeN/A42.88%-15.74%26.81%

About Fate Therapeutics, Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Fate Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.36
$2.17
-8.23%
Sep 2026
$2.38
$2.37
-6.32%
Aug 2026
$2.39
$2.53
+3.69%
Jul 2026
$2.67
$2.44
-10.13%
Jun 2026
$2.69
$2.71
-4.40%
May 2026
$1.25
$2.84
+127.20%
Apr 2026
$1.23
$1.25
+3.73%
Mar 2026
$1.44
$1.21
-18.58%
Feb 2026
$1.17
$1.48
+24.37%
Jan 2026
$1.00
$1.19
+20.93%
Dec 2025
$1.09
$0.98
-13.30%
Nov 2025
$1.37
$1.14
-16.85%

FATE Share Price FAQs

What is Fate Therapeutics, Inc. share price today?

chevron-up
Fate Therapeutics, Inc. share price today is $2.17 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Fate Therapeutics, Inc. stock?

chevron-up
The 52 week high of Fate Therapeutics, Inc. stock is $3.23, while the 52 week low is $0.95 as of 10 Oct '26.

What is FATE's market capitalisation today?

chevron-up
FATE market capitalisation is $257.77M as of October 12, 2026, at 7:07 am IST.

What is FATE's net income for the last quarter?

chevron-up
FATE's net income for the last quarter is -30.16B USD.

What is the 5 year returns of FATE?

chevron-up
The 5 year returns of FATE is -95.97% as on 10 Oct '26.

What is the high & low stock price of FATE today?

chevron-up
FATE stock price hit a high of $2.27 and low of $2.13 as of 10 Oct '26.

Can I buy FATE shares in India?

chevron-up
Yes. You can buy FATE in India by opening an international trading account.